NEIL COSKUN: Open Payments
NPI 1093814063 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 21 payments from 13 companies in 2025. Trend: 2023 $737 · 2024 $576 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $101 |
| US Implant Solutions, LLC | 1 | $72 |
| Amgen Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $23 |
| Fisher & Paykel Healthcare Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
Products named: QULIPTA, Kerendia, INSPIRE, ELIQUIS, Ozempic, FISHER & PAYKEL HEALTHCARE, MOUNJARO, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
